Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study
Yonsei med. j
; Yonsei med. j;: 48-55, 2020.
Article
in En
| WPRIM
| ID: wpr-782124
Responsible library:
WPRO
Full text:
1
Index:
WPRIM
Main subject:
Ulcer
/
Biological Products
/
Biological Therapy
/
Colitis, Ulcerative
/
Follow-Up Studies
/
Colectomy
/
Asian People
/
Emergency Service, Hospital
/
Adalimumab
/
Infliximab
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Yonsei med. j
Year:
2020
Type:
Article
Full text:
1
Index:
WPRIM
Main subject:
Ulcer
/
Biological Products
/
Biological Therapy
/
Colitis, Ulcerative
/
Follow-Up Studies
/
Colectomy
/
Asian People
/
Emergency Service, Hospital
/
Adalimumab
/
Infliximab
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Yonsei med. j
Year:
2020
Type:
Article